Cresco Labs (CRLBF) Set to Release Earnings This Wednesday

Cresco Labs (OTCMKTS:CRLBF – Get Free Report) is scheduled to release its quarterly earnings data prior to the market opening on Wednesday, March 12th. Analysts predict the company will report earnings of ($0.01) per share alongside revenue expectations of $172.10 million for the quarter.

Cresco Labs Shares Rise 3.8%

The shares of Cresco Labs, trading under OTCMKTS CRLBF, opened at $0.76 on Monday. Over the past year, the stock has seen a low of $0.72 and a high of $2.60. Currently, the company's debt-to-equity ratio stands at 1.80, with a current ratio of 1.97 and a quick ratio of 1.39. Additionally, the stock has a 50-day moving average of $0.91 and a 200-day moving average of $1.23. The market capitalization of Cresco Labs is approximately $371.57 million, with a price-to-earnings (P/E) ratio of -3.81 and a beta of 1.79.

Predictions from Wall Street Analysts

Recently, several equity analysts have provided insights on the stock. ATB Capital Markets downgraded Cresco Labs from a “strong-buy” to a “hold” rating in early December. Cormark also reduced their rating from a “moderate buy” to a “hold” in November. However, Roth Capital elevated their outlook for Cresco Labs to a “strong-buy” in a note from November 10. Currently, four analysts have assigned a hold rating, while two have issued buy ratings and another two a strong buy rating. According to MarketBeat.com, the consensus rating stands at “Moderate Buy,” with an average price target of $2.50.

About Cresco Labs

Cresco Labs Inc, along with its subsidiaries, engages in the cultivation, manufacturing, and sale of retail and medical cannabis products across the United States. The company markets its cannabis offerings under various brands, including flowers, vape pens, live resins, and extracts under the Cresco brand. It also provides a range of products under the High Supply brand, including vape carts, disposable pens, and concentrates. Their other brands feature Good News and Wonder Wellness Co, which specialize in vapes, gummies, and edibles, while Remedi offers tinctures, capsules, and salves.

Cresco, Earnings, Stocks